Zev Fima, host of @TheStreet Investor Bootcamp, interview of CV Sciences $CVSI CEO Joseph Dowling about the safety of CBD and it's future in modern day health care.
Growth rate 36% y/y as of June 2019 plus increase in retail outlets from about 3400 to 5400 in 3Q19 will lead to much higher growth for the only GRAS CBD company. 3Q 19 reports should be spectacular for this low price stock